ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • Abstract Number: 1907
    T-Bet Regulates Ahr-Mediated Th-17 Differentiation Independently of IFNγ
  • Abstract Number: 2923
    T-Cell Receptor Signaling Inhibition By CC-90005, a Selective Protein Kinase C Theta Antagonist, Reduces Antigen Mediated T-Cell Activation and Arthritis Pathology in the Mouse CIA Model
  • Abstract Number: 2222
    Tai Chi Is More Effective Than Aerobic Exercise in Treating Fibromyalgia: A Randomized Controlled Trial
  • Abstract Number: 50
    Tai Chi Significantly Modulates Resting State Functional Connectivity of the Cognitive Control Network in Fibromyalgia
  • Abstract Number: 864
    Takayasu Arteritis Developed over the Age of 40 Has Lower Levels of Interferon Gamma and Interleukin 17 at Disease Onset and Fewer Subsequent Relapses
  • Abstract Number: 2702
    Taking Fly for Understanding the Molecular Role of HLA-B27/hB2m in Spondyloarthritis
  • Abstract Number: 1097
    Tankyrase Regulates Osteoclastogenesis Via SH3BP2
  • Abstract Number: 3014
    Tapering of Adalimumab Based on Therapeutic Drug Monitoring in Rheumatoid Arthritis
  • Abstract Number: 1125
    Targeted Lipidomics Reveals Incomplete Activation of Resolution Pathways in Knee Osteoarthritis
  • Abstract Number: 1123
    Targeted Mutations Identify the Active Site of Glucocorticoid-Induced Leucine Zipper (GILZ)
  • Abstract Number: 1213
    Targeted Next-Generation Sequencing of 128 Genes Associated with Rheumatoid Arthritis
  • Abstract Number: 3177
    Targeted Nuclear Imaging for the Early Detection of Lung Involvement in Systemic Sclerosis
  • Abstract Number: 852
    Targeting Fibroblastoid-like Cells By Drug Loaded Engineered Gold Nanoparticles As a Novel Approach for ILD-SSc Treatment
  • Abstract Number: 674
    Targeting Glandular IL-21-Production in Primary Sjogren′s Syndrome Patients By Immunomodulatory Treatment
  • Abstract Number: 1109
    Targeting IL-8 and CXCR1/2 Abrogates RANKL- and ACPA-Mediated Osteoclastogenesis
  • Abstract Number: 2791
    Targeting Micro-RNAs Derived from Extracellular Vesicles to Inhibit of TLR7 and TLR8 Signaling Suppresses Inflammation in a Novel Human-Mouse Chimeric Model of Systemic Lupus Erythematosus
  • Abstract Number: 2107
    Targeting Mir-155 in Rheumatoid Arthritis B Cells Reduces Antibody Production
  • Abstract Number: 1033
    Targeting Notch-Activated M1 Macrophages Attenuates Joint Tissue Damage in a Mouse Model of Inflammatory Arthritis
  • Abstract Number: 1881
    Targeting Oncostatin M in the Target Tissue: Assessment of in-Vivo Affinity and Target Engagement of an Anti-OSM Monoclonal Antibody By Combining Blood and Skin Blister Fluid Data
  • Abstract Number: 484
    Targeting the BTK-JAK Axis in Preclinical Models of Rat Collagen-Induced Arthritis with GS-4059 in Combination with a JAK Inhibitor
  • Abstract Number: 460
    TAS5315, a Novel Bruton’s Tyrosine Kinase Inhibitor, Demonstrates Anti-Inflammatory Effect in Autoimmune Disease Models
  • Abstract Number: 1436
    TAS8274, a Highly Selective Janus Kinase 3 Inhibitor, Demonstrates Potent Efficacy in an Animal Model of Rheumatoid Arthritis
  • Abstract Number: 2599
    TCZ Improves the Pro-Atherothrombotic Profile of Rheumatoid Arthritis Patients Modulating Endothelial Dysfunction, Netosis and Inflammation
  • Abstract Number: 577
    TCZ Modulates the Production of Ccfdna Derived from RA Synovial Cells
  • Abstract Number: 439
    Temple University Hospital Rheumatology Narcotic Contract
  • Abstract Number: 903
    Temporal Arteritis: Is There Any Correlation Between Ultrasonographic Arterial Wall Involvement and the Inflammatory Cellular Infiltrate at Histological Examination?
  • Abstract Number: 1530
    Temporal Trend of Total Joint Replacement in Rheumatoid Arthritis Patients: A Survival Study
  • Abstract Number: 3172
    Temporal Trends in SLE Mortality According to Sex, Race, Ethnicity, and Geographic Region in the United States over the Past Five Decades
  • Abstract Number: 2498
    Tender Joints Is a Consistent Negative Predictor of Sustained Remission in Aggressively Treated Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1100
    Tenofovir, a Nucleoside Analog Reverse Transcriptase Inhibitor for Treatment of HIV, Promotes Osteoclast Differentiation and Decreases Osteoblast Formation By a Mechanism Depending on ATP Release and Adenosine
  • Abstract Number: 2141
    Terminal Uridylyl Transferase ZCCHC6-Dependent Generation of miRNA Diversity in Primary Human Chondrocytes
  • Abstract Number: 2924
    Terminally Differentiated CD8 T Cell Subset Has Distinct Signiture in RA
  • Abstract Number: 867
    Termination of Tocilizumab-Treatment in Giant Cell Arteritis: Follow-up of Patients after the RCT (ClinicalTrials.gov registration number: NCT01450137)
  • Abstract Number: 1106
    Test of the Spleen Tyrosine Kinase Inhibitor Fostamatinib in a Translational Joint Tissue Model Show Significant Effect on Bone, but Not on Synovial Tissue
  • Abstract Number: 1845
    TGF-β-Induced Tissue Fibrosis Is Abrogated in Mice Containing a Constitutive Genetic Deletion of Nox4 (Nox4 knockout)
  • Abstract Number: 3040
    Th17 Migration into the Synovial Fluid of Patients with Active Psoriatic Arthritis Is Enhanced By Regulatory T Cells
  • Abstract Number: 2248
    The “Financial Toxicity” of Therapy in Patients with Rheumatoid Arthritis
  • Abstract Number: 493
    The 2010 ACR/EULAR Criteria Are Not Sufficiently Accurate in the Early Identification of Autoantibody-Negative Rheumatoid Arthritis
  • Abstract Number: 102
    The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors
  • Abstract Number: 136
    The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 135
    The 8-Joint Ultrasound Score Is a Useful Marker for Monitoring Therapeutic Response in Rheumatoid Arthritis
  • Abstract Number: 1777
    The Accumulation of Organ Damage, Public Insurance Enrollment and Youth Are Associated with Increased Hospitalizations in a Population-Based Cohort of Lupus Patient
  • Abstract Number: 322
    The Activating Patients at Risk for Osteoporosis Study: A Randomized Trial within the Global Longitudinal Study of Osteoporosis in Women Cohort
  • Abstract Number: 3018
    The Analysis of Severity of Arthritis in the Intestinal Microbiota-Humanized Mice
  • Abstract Number: 449
    the Animated Activity Questionnaire to Assess Activity Limitations in Patients with Hip and Knee Osteoarthritis: Reliability, Responsiveness, and Interpretation
  • Abstract Number: 1085
    The Anti-CD38 Monoclonal Antibody TAK-079 Depletes Antibody Secreting Cells from Normal and SLE Patients
  • Abstract Number: 921
    The Anti-IL-17A Antibody Secukinumab (Cosentyx®, AIN457) Diminishes the Expression of the NFκB Pathway Modulator Iκbζ
  • Abstract Number: 165
    The Apparent Diffusion Coefficient As a Quantitative Imaging Biomarker of Therapeutic Response in Enthesitis-Related Arthritis
  • Abstract Number: 2101
    the Association Between ABO Blood Types and Venous Thromboembolism in Individuals with a Positive Antiphospholipid Antibody Profile Is Varied By Sex
  • Abstract Number: 2194
    The Association Between Arthritis and Carpal Tunnel Syndrome: National Health Interview Survey, 2010
  • Abstract Number: 3161
    The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis
  • Abstract Number: 1662
    The Association Between Radiologic Progression and Serum Levels of Potential Markers of Bone Formation in Ankylosing Spondylitis Patients
  • Abstract Number: 3157
    The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis
  • Abstract Number: 2189
    The Association of Arthritis and Lung Diseases: A Population-Based Study
  • Abstract Number: 515
    The Association of Body Mass Index with the Severity of  Magnetic Resonance Imaging-Detected Inflammation at Presentation; Opposite Effects in Early Rheumatoid Arthritis Compared to Other Arthritides and an Asymptomatic Population
  • Abstract Number: 1552
    The Association of Fatigue, Comorbidities and Anti Rheumatic Drugs in Rheumatoid Arthritis: Results from French Cohort Study of Comorbidities
  • Abstract Number: 2027
    The Association of Light and Moderate-to-Vigorous Walking with Incident Poor Health Outcomes over Two Years in People with or at High Risk of Knee Osteoarthritis
  • Abstract Number: 359
    The Association of Scheuermann’s Disease with Osteoporotic Vertebral Fracture Risk
  • Abstract Number: 2360
    The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study
  • Abstract Number: 2929
    The Baseline Th17 Lymphocytes Level Is a Predictive Marker of Good Response to Biologics in Rheumatoid Arthritis
  • Abstract Number: 1L
    The Cardiovascular Safety of Celecoxib Versus Ibuprofen or Naproxen in 24,081 Patients with Osteoarthritis or Rheumatoid Arthritis
  • Abstract Number: 3143
    The Caspase 8/RIPK3 Signaling Axis in Dendritic Cells Controls Joint Homeostasis Under Steady-State and Arthritic Conditions
  • Abstract Number: 2883
    The CD4+CD52low T Cell Contributes to the Development of Systemic Lupus Erythematosus through the CCR8/TARC Pathway
  • Abstract Number: 3079
    The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)
  • Abstract Number: 3004
    The Choosing Wisely Initiative: Is It Complete?
  • Abstract Number: 314
    The Clinical Efficacy and Safety of the Gumiganhwal-Tang in Knee Osteoarthritis: A Phase II Randomized Double Blind Placebo Controlled Study
  • Abstract Number: 2918
    The Clinical Relevance of Common ANA Patterns in Systemic Sclerosis
  • Abstract Number: 607
    The Clinical Response to Biologic and Non-Biologic Disease Modifying Antirheumatic Drugs (DMARDs) According to Gender in a French-Canadian Population with Rheumatoid Arthritis (RA)
  • Abstract Number: 2322
    The Clinical Significance of Curvilinear Bodies on Ultrastructural Examination of Muscle
  • Abstract Number: 2366
    The Clinical Utility of the Bulge Sign in Evaluating Knee Osteoarthritis
  • Abstract Number: 2723
    The Co-Occurrence of Axial Spondyloarthritis and Fibromyalgia: A National Register-Based Study
  • Abstract Number: 1581
    The Combination of IL-6 and IL-6 Receptor Levels As a Biomarker of Response to Tocilizumab in Rheumatoid Arthritis Patients
  • Abstract Number: 1691
    The Comparative Immunogenicity of Biologic Therapy and Its Clinical Relevance in Psoriatic Arthritis: A Systematic Review of the Literature
  • Abstract Number: 1564
    The Comprehensive Analysis for the Transcriptional Organization of Stimuli Responses in Fibroblast-like Synoviocytes from Rheumatoid Arthritis Patients
  • Abstract Number: 1879
    The Correlation Between Oxidized Low-Density Lipoprotein and Clinical Manifestations in Patients with Systemic Sclerosis
  • Abstract Number: 1223
    The Cost of Confronting Osteoporosis:Cost Study of a Fracture Liaison Service
  • Abstract Number: 1081
    The CRL4CRBN E3 Ubiquitin Ligase Modulator CC-220 Inhibits BAFF-Mediated Plasmablast Differentiation and Immunoglobulin Secretion from Class Switched CD27+IgD- Memory and Lupus-Associated CD27-IgD- Double Negative B-Cells
  • Abstract Number: 2365
    The Cross-Sectional and Longitudinal Associations Between Metabolic Syndrome and Hand Osteoarthritis – Data from the Framingham Study
  • Abstract Number: 532
    The DAS28 Score May Misread Disease Activity in Rheumatoid Arthritis Patients
  • Abstract Number: 3207
    The Deficiency of Adenosine Deaminase Type 2 (DADA2)—Results of Anti-TNF Treatment in a Cohort of Patients with a History of Stroke
  • Abstract Number: 2407
    The Descriptive Epidemiology of Acute Rheumatic Fever and Post-Streptococcal Reactive Arthritis in Japan
  • Abstract Number: 1607
    The Development of a New Anti–Interleukin 6 Blocker for Rheumatoid Arthritis Patients
  • Abstract Number: 1165
    The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine
  • Abstract Number: 3151
    The Diagnostic and Predictive Value of Anti-Acetylated Peptide Antibodies in RA Patients Starting Methotrexate Treatment
  • Abstract Number: 711
    The Diagnostic Value of the Symptom of Inflammatory Back Pain in the Rheumatology Setting
  • Abstract Number: 2376
    The Disease Burden of Systemic Juvenile Idiopathic Arthritis for Patients and Caregivers: An International Health Related Quality of Life Survey and Retrospective Chart Review
  • Abstract Number: 854
    The Ducas: Proposal for a Digital Ulcer Assessment Score in Scleroderma
  • Abstract Number: 754
    The Duration of Anti-Malarial Agent Intake in the First 5 Years of the Disease and Prognosis in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1237
    The Economic Burden of Dermatomyositis and Polymyositis in the US
  • Abstract Number: 2009
    The Effect of Anifrolumab on Cutaneous Manifestations and Arthritis in Moderate to Severe Systemic Lupus Erythematosus (SLE) Using Categorical SLEDAI–2K Responses and Continuous Measures of Activity As Outcome Measures
  • Abstract Number: 2494
    The Effect of Body Mass on DAS28 Response in Patients with Rheumatoid Arthritis Treated with Abatacept
  • Abstract Number: 1724
    The Effect of Certolizumab Pegol on Skin Manifestations of Psoriatic Arthritis over 4 Years of Treatment
  • Abstract Number: 1872
    The Effect of Cyclophosphamide on Pulmonary Function and Dependence on Disease Activity of Interstitial Lung Disease Associated with Systemic Sclerosis
  • Abstract Number: 2567
    The Effect of Fibroblast Growth Factor 4 on the Proliferation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis
  • Abstract Number: 3025
    The Effect of Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor on Patient-Reported Outcomes: Results from Two 24-Week Phase 2B Dose Ranging Studies
  • Abstract Number: 2627
    The Effect of Fostamatinib with Methotrexate on Circulating Biomarkers of Synovium, Cartilage and Bone Metabolism: Potential Utility for Clinical Development Decision Making in Rheumatoid Arthriti
  • Abstract Number: 361
    The Effect of Immunosuppressive and Antiresorptive Therapy on Bone Mineral Density in Lung Transplant Patients
  • Abstract Number: 1851
    The Effect of Narrow Band Ultraviolet A1 Light on Bleomycin-Induced Mouse Model of Scleroderma
  • Abstract Number: 1155
    The Effect of Nurse-Led Follow-up in Rheumatoid Arthritis. a Systematic Review and Meta-Analysis of Randomized Controlled Trails
  • Abstract Number: 2738
    The Effect of Pregnancy on Disease Activity Outcomes in Psoriatic Arthritis Patients
  • Abstract Number: 217
    The Effect of Regular Treatment on Disability in a Cohort of Patients with Gout. 
  • Abstract Number: 2920
    The Effect of Rituximab on B Cells in Skin and Peripheral Blood in Systemic Sclerosis
  • Abstract Number: 2593
    The Effect of Tofacitinib on Bone Mineral Density in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
  • Abstract Number: 956
    The Effect of Treatment Adjustments Aimed at DAS Remission on Physical Functioning in Undifferentiated and Rheumatoid Arthritis Patients in Low Disease Activity
  • Abstract Number: 114
    The Effect of Triage Assessments on Identifying Inflammatory Arthritis and Reducing Rheumatology Wait Times in Ontario
  • Abstract Number: 1523
    The Effect Size of Fibromyalgia on PG-VAS in Rheumatoid Arthritis Patients. Adjustment Proposal in DAS28-ESR
  • Abstract Number: 2315
    The Effectiveness of Social Media in Recruiting for Rare Rheumatic Diseases
  • Abstract Number: 2609
    The Effectiveness of Zoster Vaccine in RA Patients Subsequently Treated up to 19 Months with Tofacitinib
  • Abstract Number: 3026
    The Efficacy and Safety of Low Dose IL-2 Therapy in over-Treated Patients with Rheumatoid Arthritis: A Preliminary Study
  • Abstract Number: 2590
    The Efficacy of Additional Immunoadsorption on the Modulation of Disease Activity in Patients with Severe Rheumatoid Arthritis
  • Abstract Number: 452
    The Efficacy of Motivational Counselling and SMS-Reminders on Daily Sitting Time in Patients with Rheumatoid Arthritis: A Randomised Controlled Trial
  • Abstract Number: 1449
    The Efficiency of the Regulation of Ca2+ Entry through Calcium Release-Activated Calcium Channel in the Treatment of Rheumatoid Arthritis
  • Abstract Number: 2183
    The Electronic Osteoarthritis Knee and Hip Quality of Life (OAKHQOL) Questionnaire: A Useful and Valid Alternative to Measure Health-Related Quality of Life in Knee Osteoarthritis 
  • Abstract Number: 1119
    The Enhanced Expression of mRNA for Calgranulins, S100A8, S100A9 and S100A12, in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis
  • Abstract Number: 1439
    The EP4 Receptor Antagonist CR6086 Is More Effective Than Classical NSAID and DMARD Treatment in a Murine Model of Arthritis and in Human RA Synovial Explants
  • Abstract Number: 1168
    The Epidemiology of Individuals Not Fully Meeting Classification Criteria for Systemic Lupus Erythematosus (SLE): The Georgia Lupus Registry
  • Abstract Number: 1432
    The EULAR Systemic Sclerosis Impact of Disease Score – a New Patient-Reported Outcome Measure for Patients with Systemic Sclerosis Under Development
  • Abstract Number: 2213
    The Four Stages of Fibromyalgia: Potential for More Precise Treatment Approaches
  • Abstract Number: 1964
    The Frequency and Clinical Significance of IgA Anticardiolipin and Anti-β2-Glycoprotein-I Antibodies in Antiphospholipid Antibody Patients with and without Lupus
  • Abstract Number: 2193
    The Frequency of and Patient Characteristics Associated with Fear of Movement in Adults with Symptomatic Knee Osteoarthritis
  • Abstract Number: 1140
    The Future of Rheumatology: Pediatric and Adult Fellows-in-Training Results from the 2015 ACR/ARHP Workforce Study
  • Abstract Number: 3015
    The Good, the Bad and the Ugly – Refractory Rheumatoid Arthritis in 2016
  • Abstract Number: 520
    The HAQ Reversible and Irreversible Components Measuring Function in Rheumatoid Arthritis
  • Abstract Number: 1794
    The High Disease Activity State Is an Adverse Prognostic Indicator in SLE and Defines a Clinically Distinct Population
  • Abstract Number: 497
    The Identification of an ACR Score with the Optimal Discriminatory Ability Between Treatments in Patients with Early and Established Rheumatoid Arthritis
  • Abstract Number: 269
    The Immunoproteasomes Are Essential for Maintaining Myokine Production and MHC Class I Expression in Idiopathic Inflammatory Myopathies
  • Abstract Number: 1179
    The Impact of Autoimmune Disease in the Management and Prognosis of Acute Coronary Syndrome
  • Abstract Number: 2592
    The Impact of Biologic Therapy Introduction on Hip and Knee Replacement Among Rheumatoid Arthritis Patients: An Interrupted Time Series Analysis Using the Clinical Practice Research Datalink
  • Abstract Number: 1770
    The Impact of Comorbidities on Quality of Life in Systemic Lupus Erythematosus in the First 10 Years
  • Abstract Number: 18
    The Impact of Disease-Related and Contextual Factors on Work Outcomes in Chronic Inflammatory Arthritis Patients Treated with Biologics: A Systematic Review
  • Abstract Number: 1019
    The Impact of Hip and Knee Osteoarthritis on the Subsequent Risk of Incident Diabetes: A Population-Based Cohort Study
  • Abstract Number: 992
    The Impact of Inflammatory Arthritis (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, reactive arthritis) on Maternal and Neonatal Outcomes: A Population-Level Analysis
  • Abstract Number: 3084
    The Impact of Mental Health on Indicators of Disease Severity Among Patients with Inflammatory Arthritis: A Cross-Sectional and Longitudinal Investigation
  • Abstract Number: 3054
    The Impact of Obesity on Knee Osteoarthritis Symptoms and Related Biomarker Profiles in a Bariatric Surgery Cohort
  • Abstract Number: 3171
    The Impact of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases
  • Abstract Number: 17
    The Importance of Achieving Clinical Response to Treatment and Changes in Physical Ability and Quality of Life on Worker Productivity Outcomes in Rheumatoid Arthritis: Results from the British Society for Rheumatology Biologics Register
  • Abstract Number: 1427
    The Importance of Outcome Measures in Ankylosing Spondylitis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Cohort
  • Abstract Number: 540
    The Importance of Outcome Measures in Rheumatoid Arthritis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Setting
  • Abstract Number: 2346
    The Improving Motivation for Physical Activity in Arthritis Clinical Trial for Adults with Knee Osteoarthritis and Rheumatoid Arthritis
  • Abstract Number: 2900
    The Incidence and Prevalence of Systemic Sclerosis in Northwestern Part of Turkey
  • Abstract Number: 1501
    The Incidence of Interstial Lung Disease and Malignancies in Veterans with Rheumatoid Arthritis
  • Abstract Number: 1309
    The Incidence of Sexually Acquired Reactive Arthritis: A Systematic Literature Review
  • Abstract Number: 2296
    The Influence of Androgen Deprivation Therapy on Serum Uric Acid Level
  • Abstract Number: 395
    The Influence of Early Achievement of “Clinically Inactive Disease” or “Minimal Disease Activity” on Long-Term Disability Outcomes in JIA
  • Abstract Number: 2272
    The Influence of Genetic Variants on Renal Uric Acid Excretion in Response to Frusemide
  • Abstract Number: 447
    The Influence of Risk Presentation Format on Willingness to Start a Medication
  • Abstract Number: 3150
    The Initial Dose of Methotrexate per Weight Is Determinant of Disease Activity and Early DAS28 Remission in DMARD-Naive Early Rheumatoid Arthritis Patients Receiving Usual Care
  • Abstract Number: 185
    The Interferon Gene Signature Is Increased in Early DMARD Naive Rheumatoid Arthritis and Predicts a Poorer Response to Initial Therapy
  • Abstract Number: 791
    The International Consensus on Standardized Nomenclature of Antinuclear Antibody HEp-2 Cell Patterns (ICAP) Initiative – Update and Its Impact
  • Abstract Number: 1899
    The Intestinal Involvement in Systemic Sclerosis Is Characterized By a Peculiar Gut Microbiota
  • Abstract Number: 2616
    The JAK1-Selective Inhibitor Filgotinib Displays an Anti-Inflammatory Biomarker Signature in Rheumatoid Arthritis Patients
  • Abstract Number: 2786
    The Janus Kinase Inhibitor Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
  • Abstract Number: 1898
    The Lack of Association of Osteoporosis with Proton Pump Inhibitor in Scleroderma: A UK Single Centre Cohort Experience
  • Abstract Number: 654
    The Level of B-Cell Active Cytokines and Soluble B-Cell Activating Factor/a Proliferation-Inducing Ligand Receptors in Patients with Primary Sjogren’s Syndrome
  • Abstract Number: 2855
    The Long-Term Clinical Outcomes of Lupus Nephritis
  • Abstract Number: 747
    The Long-Term Outcomes on Leflunomide Treatment in Patients with Lupus Nephritis: A Twelve-Year Follow-up Study
  • Abstract Number: 2540
    The Longitudinal Impact of Biologic Use on Disability within a RA Registry
  • Abstract Number: 505
    The Longitudinal Stability of the RA Biomarkers RF and ACPA in Classifying RA Subtypes over Extended Follow up
  • Abstract Number: 2046
    The Low-Dose Intravenous Cyclophosphamide Euro-Lupus Regimen Does Not Impact the Ovarian Reserve of Lupus Patients, As Measured By Serum Anti-Mullerian Hormone Levels
  • Abstract Number: 2700
    The Lymphatic System: A Gatekeeper for Migration of Pathogenic T-Cells Towards Synovial Joints and Entheses in Psoriasis
  • Abstract Number: 440
    the Majority of Biologic Injectors Are Stored Under Suboptimal Conditions at Home
  • Abstract Number: 2145
    The Modulation of Macrophage Polarization By SIRT1 Maybe New Target Therapy in Rheumatoid Arthritis
  • Abstract Number: 1132
    The Musculoskeletal Master Educator Training Program: A New Resource and Professional Development Opportunity for Leaders in Medical Education
  • Abstract Number: 1825
    the Non-Coding Genome and the Genetics of Systemic Lupus
  • Abstract Number: 815
    The Novel Anti-BICD2 Autoantibody Potentially Predicts a Favorable Disease Course in SSc
  • Abstract Number: 2916
    The Number of Micro-Haemorrhages and Micro-Thrombosis Detected By Nailfold Videocapillaroscopy Is a Good Predictor of Disease Activity in Systemic Sclerosis: The Validation Study of NEMO Score
  • Abstract Number: 3098
    The Occurrence of Peripheral Arthritis Mutilans in Psoriatic Arthritis Is Associated with Certain Major Histocompatibility Class I Alleles
  • Abstract Number: 2243
    The Paucity of the Evidence Base for American College of Rheumatology Practice Guidelines
  • Abstract Number: 2536
    The Performance of a Single Centre Interventional Clinic in Early Rheumatoid Arthritis
  • Abstract Number: 2395
    The Performance of the Kobayashi and Egami Scores in Detecting IVIG Resistance in Kawasaki Disease in a Single Centre Canadian Cohort Treated with IVIG and Low Dose Aspirin
  • Abstract Number: 3129
    The Pharmacokinetics of Oxypurinol in Patients Treated with Hemodialysis and Allopurinol
  • Abstract Number: 900
    The Phenotype of Macrophages in the Inflamed Vascular Wall of Giant Cell Arteritis Resembles the Phenotype of Non-Classical Monocytes
  • Abstract Number: 2310
    The Predictive Risk Factors for Complication of Infection during the Treatment for Inflammatory Myopathies Complicated with Interstitial Lung Disease
  • Abstract Number: 1069
    The Predictive Value of Acl and Anti-β2GPI in Patients with Acute Deep Vein Thrombosis
  • Abstract Number: 2766
    The Predictive Value of Patient’s and Evaluator’s Global Assessment and Tender and Swollen Joint Count Differences on Treatment Efficacy in Psoriatic Arthritis: Data from a Longitudinal Multicenter Study
  • Abstract Number: 2793
    The Predictors of Sustained Complete Remission in Lupus Nephritis
  • Abstract Number: 1701
    The Presence of Depression Might be an Important Determinant of Achieving Minimal Disease Activity State in Psoriatic Arthritis
  • Abstract Number: 3
    The Presence of Rheumatoid Factor Is Associated with Lower Bone Mass in Korean Health Screening Male Subjects without Clinically Apparent Arthritis
  • Abstract Number: 2575
    The Presence of Staphylococcal Toxins in the Urine of Patients with Rheumatoid Arthritis
  • Abstract Number: 2102
    the Prevalence and Associations of IgG/a/M ANTI-β2GPI and ANTI-Domain I  Antibodies in an Antiphospholipid Syndrome (APS) Cohort of Patients from Turkey
  • Abstract Number: 693
    The Prevalence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis
  • Abstract Number: 1295
    The Prevalence of Inflammatory and Structural Lesions on MRI of the Sacroiliac Joints in Patients with Very Early Peripheral Spondyloarthritis
  • Abstract Number: 433
    The Prevalence of Latent Tuberculosis and Hepatitis B Found after Systematic Screening of Patients Starting with Biological Therapy in a Low-Endemic Area
  • Abstract Number: 2495
    The Prevalence of Loss of Response to Treatment with a Tumor Necrosis Factor Inhibitor and/or Methotrexate in Patients with Rheumatoid Arthritis
  • Abstract Number: 2453
    The Prevention, Screening, and Treatment of Congenital Heart Block from Neonatal Lupus: A Survey of Provider Practices
  • Abstract Number: 1035
    The Prognostic Value of Different Auto-Antibodies for Arthritis Development in Patients with Clinically Suspect Arthralgia
  • Abstract Number: 2588
    The Real World Comparative Safety of Certolizumab Pegol (CZP) As Compared to Other TNFi in a National US Cohort
  • Abstract Number: 652
    The Reasons for Discontinuation of Combination Therapy with Methotrexate and Tumor Necrosis Factor Inhibitors Versus Triple Therapy Differ Significantly Because of Higher Adverse Events with Triple Therapy
  • Abstract Number: 814
    The Regulatory B Cells Ameliorate Skin Sclerosis, Lung Fibrosis, and Autoimmunity Via an Anti-Oxidative Effect in Systemic Sclerosis Model Mice
  • Abstract Number: 313
    The Relation of Serum Urate to Radiographic Knee and Hand Osteoarthritis
  • Abstract Number: 345
    The Relationship Between Anti-Cyclic Citrullinated Peptide (anti-CCP) Levels and Bone Mineral Density (BMD) or Fragility Fracture in Patients with Rheumatoid Arthritis (RA)
  • Abstract Number: 2338
    The Relationship Between Anxiety and Physical Activity Participation in Adults with Persistent Knee Pain and the Moderating Effect of Neighborhood Social Cohesion
  • Abstract Number: 506
    The Relationship Between Elevations in CRP with Physical Function and Radiographic Progression over the Long-Term in Patients with Rheumatoid Arthritis
  • Abstract Number: 1712
    The Relationship Between Physical Functioning and Work for People with Psoriatic Arthritis: Results from a Large Real-World Study in 16 Countries
  • Abstract Number: 529
    The Relationship Between Promis and CDAI Scores, Disease Duration, Age and Gender in Patients with Rheumatoid Arthritis
  • Abstract Number: 240
    The Relationship Between Serum Cholinesterase, Number of Organ Involvement and Fibrotic Markers in Japanese Patients with IgG4-Related Disease
  • Abstract Number: 117
    The Relationship Between Socioeconomic Factors and Dmards Use in Rheumatoid Arthritis
  • Abstract Number: 855
    The Relationship Between Systemic Sclerosis and Breast Cancer and the Effects on Treatment Outcome
  • Abstract Number: 495
    The Relative Performance of 28-Joint Disease Activity Score Based on C-Reactive Protein with Three Versus Four Components in Patients with Rheumatoid Arthritis
  • Abstract Number: 1274
    The Reproducibility of a Semi-Automatic Algorithm in the Detection of Cortical Breaks and Adjacent Trabecular Bone Loss in Scan-Rescan Data from Patients with Early Arthritis
  • Abstract Number: 1324
    The Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
  • Abstract Number: 1013
    The Risk of Colchicine Associated Myopathy in Gout: Influence of Concomitant Use of Statin
  • Abstract Number: 1705
    The Risk of Fracture Among Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis
  • Abstract Number: 402
    The Risk of Hospitalized Infection Associated with Initiation of Abatacept Versus TNF Inhibitors in Juvenile Idiopathic Arthritis
  • Abstract Number: 1074
    The Risk of Obstetric Complications and the Effects of Treatment in Women with Low Titer and Medium-High Titer Anti-Phospholipid Antibodies
  • Abstract Number: 1784
    The Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Lupus Erythematosus: A Population-Based Study
  • Abstract Number: 1993
    The Risk of Stroke in Patients with Rheumatoid Arthritis and the Association with Competing Adverse Events
  • Abstract Number: 336
    The Risk of Subsequent Osteoporotic Fractures Is Decreased in Patients Experiencing Fracture While on Denosumab
  • Abstract Number: 1022
    The Risk of Symptomatic Knee Osteoarthritis after Arthroscopic Meniscus Repair Vs Partial Meniscectomy Vs the General Population
  • Abstract Number: 818
    The Role of Endothelin 1 in Activation of Vascular Smooth Muscle Cells in Systemic Sclerosis; Increased Cell Proliferation and Resistance to Apoptosis Mediated By Endotehlin B Receptors
  • Abstract Number: 1749
    The Role of Mucosal-Associated Invariant T (MAIT) Cells in Lupus Dermatitis
  • Abstract Number: 1377
    The Role of Muscle MRI in Detecting a Flare-up of Juvenile Dermatomyositis
  • Abstract Number: 1574
    The Role of Shelterin Deficiency in the Senescence in T Cells of Rheumatoid Arthritis
  • Abstract Number: 1830
    The Role of Tripartite Motif-Containing 21 in Interferon Signature of Systemic Lupus Erythematosus
  • Abstract Number: 1361
    The Role of Von Willebrand Factor Antigen As a Disease Biomarker in the Clinical Assessment of Children with Juvenile Dermatomyositis
  • Abstract Number: 204
    The Safety and Efficacy of Allopurinol Dose Escalation in People with Gout, a Randomised Controlled Trial
  • Abstract Number: 200
    The Safety and Efficacy of Benzbromarone in Gout in Aotearoa New Zealand
  • Abstract Number: 970
    The Serotonin Receptor 2 Inhibitor Terguride Has Beneficial Effects on Skin Fibrosis: Results from a Phase 2 Proof of Concept Study
  • Abstract Number: 2587
    The Serum Level of Reactive Oxygen Metabolities (ROM) at 12 Weeks during Treatment with Biologic Agents for Rheumatoid Arthritis Is a Predictor for the 52-Week Remission
  • Abstract Number: 527
    The Summed Bilateral Elbow Extension Angle in Rheumatoid Arthritis Correlates with the DAS28-CRP(4) and May be an Independent Marker of Bad Prognosis
  • Abstract Number: 2906
    The Survival and Prognostic Factors of Patients with Systemic Sclerosis Turkish Experience
  • Abstract Number: 2015
    The Systemic Sclerosis Disease State Is Associated with Specific Alterations in Gastrointestinal Microbiota in Two Independent Cohorts
  • Abstract Number: 458
    The TAM Receptors Axl and Mer Play a Protective Role in a Temporal and Spatial Manner in Inflammatory Arthritis
  • Abstract Number: 668
    The TNFAIP3 F127C Coding Variation in Sjogren’s Syndrome: Results from a Greek Cohort
  • Abstract Number: 1909
    The Transcription Factor Fra2 Is Playing a Key Role in Treg Development and Autoimmunity
  • Abstract Number: 662
    The Unusual Cross-Reactivity of Anti Muscarinic Receptor 3 Monclonal Antibodies Derived from Salivary Glands of Sjögren’s Syndrome Patients to Ro Peptides
  • Abstract Number: 1186
    The Use of Clinical Mucosal Manifestations to Differentiate Patients with Lupus and Dermatomyositis: Transversal, Retrospective and Analytical Study of 116 Patients
  • Abstract Number: 781
    The Use of Rituximab in Newly Diagnosed Systemic Lupus Erythematosus Patients: Long Term Steroid Saving Capacity and Clinical Effectiveness
  • Abstract Number: 141
    The Usefulness of SMI Technology on Ultrasound for the Evaluation of Active Synovitis in Patients with Rheumatoid Arthritis
  • Abstract Number: 1290
    The Usefulness of Volumetric Parameters of FDG PET/CT for Reflecting Disease Activity in Polymyositis/Dermatomyositis Patients
  • Abstract Number: 889
    The Utility of Patient-Reported Outcomes in Predicting Disease Activity in Patients with Takayasu’s Arteritis
  • Abstract Number: 10
    The Utility of Screening for Infectious Diseases in Recipients of Anti-TNF-α Therapy
  • Abstract Number: 3181
    The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis
  • Abstract Number: 320
    The Value of Adjusting for Physical Activity When Measuring Osteoarthritis-Related Pain
  • Abstract Number: 2425
    The Vasculopathy of Juvenile Dermatomyositis (JDM); Evidence of Persistent Endothelial Injury, Hypercoagulability, Subclinical Inflammation and Increased Arterial Stiffness
  • Abstract Number: 1139
    The Virtual Rheumatology Clinic: Virtual Patients for Resident Education in Rheumatology
  • Abstract Number: 1447
    Therapeutic Blockade of Interleukin-6 Trans-Signalling Restores Vascular Function in Murine Collagen Induced Arthritis
  • Abstract Number: 2666
    Therapeutic Efficacy of Iguratimod in Patients with Primary Sjogren’s Syndrome
  • Abstract Number: 2889
    Therapeutic Plasma Exchange for the Treatment of Raynaud’s and Digital Ulcers in Systemic Sclerosis: A Systematic Review
  • Abstract Number: 1448
    Therapeutic Role of a Novel Histone Deacetylase 6 Inhibitor, CKD-M808, in Rheumatoid Arthritis
  • Abstract Number: 1905
    Therapeutic Targeting of JAK/STAT Pathway Inhibits Follicular Helper T Cell Maturation and Function
  • Abstract Number: 617
    Therapy in Patients with Rheumatoid Arthritis (RA) with Inadequate Response to Tumor Necrosis Factor Alpha Inhibitors (TNFi): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs
  • Abstract Number: 2605
    Therapy with Biologic Agents after Diagnosis of Solid Malignancies; Results from the Corrona Registry
  • Abstract Number: 560
    There Is No Further Gain from Calculating Disease Activity Score in 28 Joints with High Sensitivity Assays of C-Reactive Protein Because of High Intraindividual Variability of CRP: A Cross Sectional Study and Theoretical Consideration
  • Abstract Number: 2308
    Thigh Muscle MRI Reveals Extensive Muscle Edema and Early Fatty Replacement in Patients with Immune-Mediated Necrotizing Myopathy
  • Abstract Number: 1175
    Thirty Day Readmission Rates for Patients Diagnosed with Systemic Lupus Erythematosus: Analysis at a Tertiary Care Center
  • Abstract Number: 2080
    Three Simple Tests to Raise the Index of Suspicion for Fibromyalgia in Primary Care
  • Abstract Number: 2505
    Thresholds of Benefit-Risk Trade-Offs from the Patient Perspective for Treatment Decisions in Moderate-to-Severe Rheumatoid Arthritis
  • Abstract Number: 2964
    Thromboangiitis Obliterans (Buerger’s disease) : An Observational Study of 174 Patients
  • Abstract Number: 1963
    Thrombospondin-1 Is Elevated in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Free Active TGF-b1 Levels, IL-1b and IL-17A
  • Abstract Number: 653
    Thrombospondin-1 Is Highly Expressed By Salivary Gland Epithelial Cells of Sjögren’s Syndrome Patients, Both Constitutively and upon Exposure to Necrotic Cells Debris
  • Abstract Number: 2597
    Time to Initiation of Biologic Agents Is Associated with Glucocorticoid Use: Results from the Corrona Registry
  • Abstract Number: 840
    Time Trends in Incidence and Mortality of Systemic Sclerosis in Denmark from 1995-2011: A Nationwide Cohort Study
  • Abstract Number: 2711
    Tissue-Resident IL-23 Responsive Innate T Cells in Mice Comprise Tcrαβ+ and TCRγδ+ Subsets with Overlapping Function
  • Abstract Number: 2057
    TLR-7-Mediated Lupus Nephritis Flares Are Independent of Type I Interferon Signaling
  • Abstract Number: 2526
    TNF Blocker Concentrations or Detection of Antibodies Against Anti-TNF before a Tapering Process Are Not Predictive to Relapse
  • Abstract Number: 1922
    TNF-α and IL-6 Induced Upregulation of CCR5 and CXCR3 Participate in Vδ2 Chemotaxis in RA
  • Abstract Number: 1682
    Tnfα Inhibitors Are Associated with Reduced Progression of Carotid Atherosclerotic Plaques By Ultrasound and an Improvement in Aortic Arch Vascular Inflammation By 18-FDG PET/CT in Psoriasis and Psoriatic Arthritis Patients – a Prospective Study from Two Cohorts
  • Abstract Number: 2499
    Tocilizumab Achieves Rapid Reduction of Disease Activity and Has Beneficial Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis
  • Abstract Number: 977
    Tocilizumab As an Add-on Therapy to Glucocorticoids during the First 3 Months of Treatment of Giant Cell Arteritis: Results of a French Multicenter Prospective Open-Label Study
  • Abstract Number: 3183
    Tocilizumab for the Treatment of Giant Cell Arteritis – MR-Angiography Results from the First Randomized Placebo-Controlled Trial 
  • Abstract Number: 1336
    Tocilizumab for Uveitic Cystoid Macular Edema Refractory to Other Synthetic and Biological Immunosuppressive Drugs. Multicenter Study of 25 Patients
  • Abstract Number: 955
    Tocilizumab Infusion Intervals Can be Extended to 5 or 6 Weeks in RA Patients Who Sustained Low Disease Activity By 4 Weeks Interval of Tocilizumab Infusion
  • Abstract Number: 2502
    Tocilizumab Therapy Reduces Corrected QT Interval in Patients with Rheumatoid Arthritis without Cardiac Symptoms
  • Abstract Number: 2580
    Tofacitinib Do Not Get Worse Subclinical Atherosclerosis Despite up-Regulating Serum Cholesterol in Methotrexate-Resistant Active Rheumatoid Arthritis Patients
  • Abstract Number: 2600
    Tofacitinib Is Associated with an Impaired Function of NK Cells and a Defective Immunosurveillance Against B-Cell Lymphomas
  • Abstract Number: 1438
    Tofacitinib Restores Reverse Cholesterol Transport Inhibition Induced By Inflammation. Understanding the Lipid Paradox
  • Abstract Number: 1647
    Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Rheumatoid Arthritis: Safety and Efficacy in Open-Label, Long-Term Extension Studies over 8 Years
  • Abstract Number: 1643
    Tofacitinib: Treatment Outcomes in Seropositive Versus Seronegative Patients in a Phase 3 RA Population
  • Abstract Number: 1661
    Toll-like Receptor 4 Induced IL-20 and IL-24 Stimulate Osteoblast Mineralization and Are Increased in Spondyloarthritis
  • Abstract Number: 2300
    Tophaceous Gout and the Risk of Mortality: A General Population-Based Study
  • Abstract Number: 2357
    Topical Application of Aceclofenac Might NOT Produce a Significant Increase of Blood Pressure in Osteoarthritic Patients – a Continuous Automated Blood Pressure Monitor Study
  • Abstract Number: 3167
    Total and Glucocorticoid-Related Damage Accrual in the Systemic Lupus International Collaborating Clinics Inception Cohort
  • Abstract Number: 1406
    Towards Harmonized Data Collection in Rheumatoid Arthritis (RA): The EULAR Task Force for Standardizing a Minimum Data Collection for RA Observational Research
  • Abstract Number: 2196
    Trajectories and Predictors of Fear-Avoidance in Persons with Rheumatoid Arthritis. a Longitudinal Observational Study
  • Abstract Number: 2273
    Trans-Ancestral Meta-Analysis Identifies Nine New Loci Associated with Serum Uric Acid Concentrations
  • Abstract Number: 2138
    Transcriptional Analysis of Synovial Tissue Reveals Sustained Inflammatory Chemokine Expression Despite Minimal Histopathologic Change in the Destabilization of Medial Meniscus Model of Murine Knee Osteoarthritis
  • Abstract Number: 1200
    Transcriptional Profiling of Early RA Synovial Tissue Reveals the Impact of Triple DMARD Treatment on T Cell Activation Pathways
  • Abstract Number: 2455
    Transcriptome Profile of Cells Isolated from a CHB Heart Support an Exuberant Inflammatory ⁄Pro-Fibrotic Cascade
  • Abstract Number: 2426
    Transcriptomic Analysis of Immune Subsets in Juvenile Dermatomyositis before and after Treatment Identifies Novel Pathways Involved in Pathogenesis
  • Abstract Number: 96
    Transforming Healthcare in Rheumatology: From Inpatient to Outpatient Care without Reductions in Healthcare Quality
  • Abstract Number: 1575
    Transient Circulatory Existence of Multipotential Stromal Cells Is Unlikely to Contribute to the Pathogenesis of Rheumatoid Arthritis
  • Abstract Number: 2131
    Transient Receptor Potential Ankyrin 1 (TRPA1) Is Functionally Expressed in Primary Human Osteoarthritic Chondrocytes and Mediates Cartilage Destruction and Joint Pain in the Mia-Model of Osteoarthritis
  • Abstract Number: 2903
    Transition of Nailfold Microangiopathy throughout Different Patterns of Microvascular Damage and Correlations with Organ Involvement in Systemic Sclerosis: A Twelve Year Follow-up
  • Abstract Number: 1399
    Transitioning Lupus Patients from Pediatric to Adult Rheumatology
  • Abstract Number: 2785
    Translatable in Vitro Immunocyte Functional Measures of CC-292 and CC-90008 Inhibitors of the Bruton’s Tyrosine Kinase (Btk)/Tec Family and the Pathology Observed in the MLR/Lpr Mouse Model of Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 2470
    Treat to Target: Theoretical Agreement Vs Daily Applicability
  • Abstract Number: 3212
    Treat-to-Target in RA: Does Early Simplified Disease Activity Index (SDAI) Remission Lead to Better 5-Year Functional Outcomes Than SDAI Low Disease Activity?
  • Abstract Number: 1700
    Treating Psoriatic Arthritis (PsA) to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) That Reflects Disease Activity in Psa
  • Abstract Number: 898
    Treatment and Outcome of Patients with a Diagnosis of Healed Arteritis on Temporal Artery Biopsy
  • Abstract Number: 3067
    Treatment Decisions Following Diagnosis of Cancer during TNFi Inhibitor Treatment in Patients with Rheumatoid Arthritis: Results from the BSRBR-RA
  • Abstract Number: 1928
    Treatment of ANCA Associated Vasculitis in the Very Elderly
  • Abstract Number: 1453
    Treatment of BAFF Transgenic Mice with Anti-TNF: Monoclonals Are Associated with a Higher Risk of Lymphoma Than Etanercept
  • Abstract Number: 2977
    Treatment of Cryoglobulinemic Vasculitis with Sofosbuvir in Four Combination Protocols
  • Abstract Number: 963
    Treatment of Homocysteine Improves Urine Protein/Cr Ratio in SLE
  • Abstract Number: 2694
    Treatment of ZAP-70 Mutant SKG Mice with Anti-IL-23 Antibody Alters Fecal Microbiota Composition and Prevents Outgrowth of Bacteria Associated with Susceptibility to Spondyloarthritis and Ileitis
  • Abstract Number: 84
    Treatment Outcomes and Predictors of Patient Support Program Use Among Patients with Rheumatoid Arthritis: Results from a Post-Marketing Observational Study (PMOS)
  • Abstract Number: 2225
    Treatment Outcomes of Newly and Formerly Diagnosed Patients with Fibromyalgia after Fibromyalgia Treatment Program
  • Abstract Number: 2729
    Treatment Patterns, Unmet Need, and Impact of Psoriatic Arthritis on Patient-Reported Outcomes in the United States
  • Abstract Number: 2253
    Treatment Persistence with Subcutaneous TNF-Alpha Inhibitors in France
  • Abstract Number: 1588
    Treatment with BI 655064 (Antagonistic Anti-CD40 Antibody) Modulates Clinical and Biomarker Parameters Associated with Rheumatoid Arthritis (RA)
  • Abstract Number: 177
    Treatment with Dexamethasone and Monophosphoryl Lipid a Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers the Ability to Modulate CD4+ T Cell Responses
  • Abstract Number: 702
    Treatment with Golimumab or Infliximab Reduces Health Resource Utilization and Increases Work Productivity in Patients with Ankylosing Spondylitis in a Large, Prospective Real-Life Cohort
  • Abstract Number: 906
    Treatment with Methotrexate and Risk of Relapses in Patients with Giant Cell Arteritis in Clinical Practice
  • Abstract Number: 1617
    Treatment with Sirukumab, an Anti-IL6 Cytokine Monoclonal Antibody, Improves Fatigue and Health-Related Physical and Emotional Well Being in Patients with Active Rheumatoid Arthritis Refractory to Conventional or Biologic Therapy: Results of 2 Global, Placebo-Controlled, Phase 3 Trials
  • Abstract Number: 2104
    Treatment with Tocilizumab Decreases CXCL13 Expression in Cultured Temporal Arteries from Patients with Giant Cell Arteritis
  • Abstract Number: 1650
    Treatment with Tofacitinib Inhibits Human Naive B Lymphocyte Development and Function in Vitro
  • Abstract Number: 1044
    Treatment with Tofacitinib Is Associated with Clinically Meaningful Reductions in Axial MRI Inflammation in Patients with Ankylosing Spondylitis
  • Abstract Number: 2645
    Treatments for Early Rheumatoid Arthritis (RA): A Systematic Review of Randomized Controlled Trials
  • Abstract Number: 2433
    Trends  in Use of Hydroxychloroquine during Pregnancy in SLE Patients from 2001 to 2012
  • Abstract Number: 2986
    Trends and Determinants of Osteoporosis Prevention and Management in Patients with Rheumatoid Arthritis Compared to Osteoarthritis
  • Abstract Number: 2631
    Trends and Factors Associated with Use of Biologic Agents As Monotherapy Among US Patients with Rheumatoid Arthritis
  • Abstract Number: 2303
    Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada from 2000-2011
  • Abstract Number: 1505
    Trends in Hospitalizations for Infections in US Patients with Rheumatoid Arthritis, 1993-2013
  • Abstract Number: 2331
    Trends in Joint Replacement Surgery in Patients with Rheumatoid Arthritis
  • Abstract Number: 1365
    Trends in Medication Usage in Patients with Juvenile Dermatomyositis
  • Abstract Number: 1510
    Trends in the Occurrence of Malignancy in Japanese Patients with Rheumatoid Arthritis Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort during a 14-Year Observation Period
  • Abstract Number: 568
    Triggering Receptor Expressed on Myeloid Cells (TREM) As a Novel Indicator of Disease Progression in ‘at-Risk’ Individuals
  • Abstract Number: 2581
    Tripterygium Wilfordii Hook F Applied Topically in Patients with Active Rheumatoid Arthritis
  • Abstract Number: 1675
    Triptolide Inhibits Th17 Differentation By JAK2/STAT3 Signal Pathway in Inflammation of Ankylosing Spondylitis
  • Abstract Number: 2006
    Tuberculosis Incidence in Ankylosing Spondylitis, Psoriatic Arthritis, and Other Spondyloarthropathies in Sweden: A Population-Based Cohort Study
  • Abstract Number: 964
    Tubulointerstitial Damage Is an Independent Predictor of End Stage Renal Disease in Lupus Nephritis Patients with Mild to Moderate Renal Impairment
  • Abstract Number: 2557
    Tumor Necrosis Factor (TNF) Sensitizes Rheumatoid Synovial Fibroblasts to TRPA1-Mediated Calcium Flux, Anti-Proliferation and Cell Death
  • Abstract Number: 2982
    Tumor Necrosis Factor Inhibitors and the Risk of Malignancy in the Treatment of Juvenile Idiopathic Arthritis
  • Abstract Number: 1129
    Tumor Necrosis Factor Receptor 2 Is Crucial for Regulatory T Cells Activity with Consequences in a Model of Chronic Inflammation and in Anti-TNF Treated Rheumatoid Arthritis
  • Abstract Number: 382
    Tumor Necrosis Factor-α -308 a/G Gene Polymorphism in Children with Juvenile Idiopathic Arthritis: Relation to Disease Activity, Damage and Disability
  • Abstract Number: 19
    Tumour Necrosis Factor Inhibition Is Associated with Weight Gain in Patients with Inflammatory Arthritis
  • Abstract Number: 2708
    Type 17 Immunity in Spondyloarthritis Is Expanded Across Multiple Lymphocyte Subsets
  • Abstract Number: 2068
    Type 2 Innate Lymphoid Cells – Cellular Source of Profibrotic Mediators Rapidly and Persistently Recruited in Experimental Fibrosis and Systemic Sclerosis
  • Abstract Number: 1669
    Type 3 Innate Lymphoid Cells Numbers in Peripheral Blood Predict Ustekinumab (Stelara) Therapy Responsiveness in Psoriatic Disease Cases with Subclinical Imaging Enthesopathy
  • Abstract Number: 1340
    Type and Frequency of Immune-Related Adverse Reactions in Patients Treated with Pembrolizumab (Keytruda), a Monoclonal Antibody Directed Against PD-1, in Advanced Melanoma at a Single Institution
  • Abstract Number: 1827
    Type I IFN Signature Low and High SLE Subjects with Moderate to Severe Disease Activity Have Distinct Gene Expression Signatures of Immunologic Pathways and Cell Types
  • Abstract Number: 1082
    Type I/II Interferon Commits to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 479
    Type II Collagen Secreted from Articular Chondrocytes Is Mainly Destroyed By Cathepsin S in RA Mice
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences